Studies indicating a role of progerin in the modulation of the NRF2 pathway, together with its role in other cellular functions such as autophagy, have led to the proposal that pharmacological regulation of this pathway could be used as a therapy for progeria.31, 33, 34. Here, LMNA is linked to progeroid syndrome.